BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$0.81
+0.00 (+0.41%)
As of Mar 25, 5:40 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +5,372.2% upside
Low Target $28.75
Average Target $44.56
High Target $50.07
Current Price $0.81
Current
$0.81
Target
$44.56
$28.75 $44.56 avg $50.07
Scenario Analysis
Bear Case
$28.75
3,430.6%
Low target
Base Case
$44.56
+5,372.2%
Avg target
Bull Case
$50.07
+6,048.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.19
-31.6% from high
52-Week Low
$0.54
+51.9% from low
Target vs 52W High
$44.56
+3,644.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%